1 - Convalida MoH

Theranostic-guided corneal cross-linking randomized clinical study granted by the Ministry of Health

We are pleased to communicate that the randomized clinical study RSKC001 has been granted by the Italian Ministry of Health according to new Medical Device Regulation (MDR) 2017/745.
The scope of the study is to validate the theranostic-guided corneal cross-linking for precise and personalized keratoconus management.
Follow us on www.regensight.com or contact us at clinicaltrials@regensight.com to know more about the study.

Comments are closed.